DBV Technologies Receives IND Clearance From FDA To Begin Clinical Trial In Peanut Allergy
Tuesday, Aug. 31st 2010 6:14 AM
DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application.
Related posts:
- Consortium Of Food Allergy Research Led By Mount Sinai Benefits From $29.9 Million Grant Mount Sinai School of Medicine has announced that the National Institutes of Health (NIH) has renewed its funding of the Consortium of Food Allergy Research (CoFAR), providing an additional $29.9 million toward genetic research and the prevention and treatment of food allergy. Mount Sinai is the primary research site for CoFAR, leading seven other institutions […]...
- Comprehensive US Food Allergy Guidelines Issued By NIH-Sponsored Panel An expert panel sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has issued comprehensive U.S. guidelines to assist health care professionals in diagnosing food allergy and managing the care of people with the disease....
- Share of Cost, Allergy Shots Are Helpful For Some Asthmatics, Risky For Others Allergy shots can reduce symptoms of asthma, use of inhaled medications and allergy-related asthma attacks, confirms an updated review of studies. Yet, the treatment can also cause systemic side effects that range from a stuffy nose to fatal anaphylactic shock....
- Share of Cost, Release Of Official Food Allergy Treatment Guidelines – Protocol Also Designed To Aid Physicians In Diagnosis Share of Cost, Release Of Official Food Allergy Treatment Guidelines - Protocol Also Designed To Aid Physicians In Diagnosis...
- Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment...
- 5.9 Million US Kids Have Food Allergies Approximately 8% of US children have some kind of food allergy, researchers from Northwestern University Feinberg School of Medicine reported in the journal Pediatrics. 38.7% of those with a food allergy have a history of severe reactions, while 30.4% are allergic to several foods, the authors added....
- Phadia First Company To Receive FDA Clearance Of Recombinant Allergen Component Tests Phadia, the global leader in allergy and autoimmunity diagnostics, today announced the FDA clearance of recombinant ImmunoCAP® Allergen Components for marketing in the United States. The FDA clearance applies to all of Phadia’s instrument platforms....
- Share of Cost, Medi-Cal, NICE Consults On Draft Guideline On Food Allergies In Children NICE has opened the consultation on its draft clinical guideline on the diagnosis and assessment of food allergies in children and young people. Its aim is to support GPs and other health professionals in primary care and community settings in recognising the signs and symptoms of food allergy, by giving clear recommendations on taking allergy-focussed […]...
- 8 Percent Of U.S. Children Have Food Allergies A large, national study of food allergies in the U.S. finds that more children have allergies, including severe allergies, than previously thought. The study, “The Prevalence, Severity and Distribution of Childhood Food Allergy in the United States,” published in the July 2011 issue of Pediatrics (published online June 20), found 8 percent of children under […]...
- Childhood Food Allergy In The US Affects 8 Percent Of Children Under 18 A national study of food allergies in the US, the largest of its kind, finds that more children have food allergies than previously reported....
Posted on Tuesday, Aug. 31st 2010 6:14 AM | by Share of Cost | in Share of Cost | No Comments »